Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	complement component C3b binding	CFH CFHR4 CFHR3	5.57e-06	12	60	3	GO:0001851
GeneOntologyMolecularFunction	opsonin binding	CFH CFHR4 CFHR3	5.66e-05	25	60	3	GO:0001846
GeneOntologyMolecularFunction	complement binding	CFH CFHR4 CFHR3	1.20e-04	32	60	3	GO:0001848
GeneOntologyBiologicalProcess	response to dietary excess	CFH APPL2 WNK4 CFHR4	9.82e-06	47	59	4	GO:0002021
GeneOntologyCellularComponent	symbiont cell surface	CFH CFHR4	2.40e-04	8	62	2	GO:0106139
GeneOntologyCellularComponent	other organism part	CFH CFHR4	3.07e-04	9	62	2	GO:0044217
MousePheno	artery occlusion	CFH CFHR4	1.11e-05	2	47	2	MP:0006134
MousePheno	abnormal hepatic portal vein thrombosis	CFH CFHR4	1.11e-05	2	47	2	MP:0031159
MousePheno	white pupil	CFH CFHR4	1.11e-05	2	47	2	MP:0006242
MousePheno	decreased serum complement activity	CFH CFHR4	1.11e-05	2	47	2	MP:0012553
MousePheno	decreased complement C5 level	CFH CFHR4	1.11e-05	2	47	2	MP:0012609
MousePheno	abnormal complement C5 level	CFH CFHR4	1.11e-05	2	47	2	MP:0012608
MousePheno	abnormal kidney venous thrombosis	CFH CFHR4	3.31e-05	3	47	2	MP:0031161
MousePheno	increased susceptilbility to retina ischemic injury	CFH CFHR4	3.31e-05	3	47	2	MP:0012049
MousePheno	increased susceptibility to type III hypersensitivity reaction	CFH CFHR4	6.61e-05	4	47	2	MP:0005615
MousePheno	mesangial cell interposition	CFH CFHR4	6.61e-05	4	47	2	MP:0011512
MousePheno	abnormal brain thrombosis	CFH CFHR4	6.61e-05	4	47	2	MP:0031168
MousePheno	abnormal response to retina ischemic injury	CFH CFHR4	6.61e-05	4	47	2	MP:0012048
MousePheno	decreased circulating complement protein level	CFH CFHR4	6.61e-05	4	47	2	MP:0020216
MousePheno	increased creatine level	CFH CFHR4	6.61e-05	4	47	2	MP:0010061
MousePheno	abnormal venous thrombosis	CFH CFHR4	1.10e-04	5	47	2	MP:0031158
MousePheno	abnormal lung thrombosis	CFH CFHR4	1.10e-04	5	47	2	MP:0031167
MousePheno	abnormal gas homeostasis	CLSTN3 SEPSECS GPR50 ZFHX4 STAC3 KIF5A EPAS1 WNK4 CLDN2	1.47e-04	600	47	9	MP:0003948
MousePheno	abnormal circulating complement protein level	CFH CFHR4	1.65e-04	6	47	2	MP:0010215
MousePheno	abnormal somatic nervous system physiology	TAS1R3 L1CAM SLC26A5 EPAS1	1.70e-04	83	47	4	MP:0005423
MousePheno	renal glomerular immunoglobulin deposits	CFH TLR7 CFHR4	1.98e-04	34	47	3	MP:0020519
MousePheno	abnormal oxygen level	SEPSECS ZFHX4 STAC3 KIF5A EPAS1 CLDN2	2.04e-04	256	47	6	MP:0001574
MousePheno	abnormal glomerular capillary thrombosis	CFH CFHR4	2.30e-04	7	47	2	MP:0011508
MousePheno	brain ischemia	CFH CFHR4	3.06e-04	8	47	2	MP:0006080
MousePheno	renal glomerular protein deposits	CFH TLR7 CFHR4	3.73e-04	42	47	3	MP:0020518
MousePheno	abnormal complement protein level	CFH CFHR4	3.92e-04	9	47	2	MP:0011566
MousePheno	abnormal creatine level	CFH CFHR4	3.92e-04	9	47	2	MP:0010060
MousePheno	expanded mesangial matrix	CFH TLR7 CFHR4	4.89e-04	46	47	3	MP:0011353
MousePheno	abnormal type III hypersensitivity reaction	CFH CFHR4	4.89e-04	10	47	2	MP:0002533
MousePheno	abnormal kidney thrombosis	CFH CFHR4	4.89e-04	10	47	2	MP:0011507
MousePheno	abnormal mesangial matrix morphology	CFH TLR7 CFHR4	6.62e-04	51	47	3	MP:0011338
MousePheno	paralysis	CFH L1CAM STAC3 CFHR4	6.71e-04	119	47	4	MP:0000753
MousePheno	abnormal visual acuity	CFH CFHR4	8.43e-04	13	47	2	MP:0011832
MousePheno	decreased visual acuity	CFH CFHR4	8.43e-04	13	47	2	MP:0006149
MousePheno	abnormal Bruch membrane morphology	CFH CFHR4	9.81e-04	14	47	2	MP:0005239
MousePheno	decreased mean corpuscular hemoglobin concentration	SEPSECS APPL2 MKRN2 TENT5C	1.11e-03	136	47	4	MP:0005642
MousePheno	retina detachment	CFH CFHR4	1.13e-03	15	47	2	MP:0003099
Domain	Sushi	CFH CFHR4 CFHR3	5.93e-04	52	59	3	PF00084
Domain	CCP	CFH CFHR4 CFHR3	6.62e-04	54	59	3	SM00032
Domain	SUSHI	CFH CFHR4 CFHR3	7.37e-04	56	59	3	PS50923
Domain	PMG	KRTAP25-1 KRTAP24-1	7.48e-04	13	59	2	PF05287
Domain	KRTAP_PMG	KRTAP25-1 KRTAP24-1	7.48e-04	13	59	2	IPR007951
Domain	Sushi_SCR_CCP_dom	CFH CFHR4 CFHR3	7.76e-04	57	59	3	IPR000436
Domain	CNH	CDC42BPA NRK	8.71e-04	14	59	2	SM00036
Domain	CNH	CDC42BPA NRK	1.00e-03	15	59	2	PF00780
Domain	CNH	CDC42BPA NRK	1.00e-03	15	59	2	PS50219
Domain	CNH_dom	CDC42BPA NRK	1.00e-03	15	59	2	IPR001180
Domain	-	CLSTN3 NRXN1 USH2A	3.37e-03	95	59	3	2.60.120.200
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR	CFH CFHR4 CFHR3	5.64e-07	6	44	3	M47880
Pathway	REACTOME_COMPLEMENT_CASCADE	IGKV1-39 CFH IGKV1D-39 CFHR4 CFHR3	2.79e-05	115	44	5	M19752
Pubmed	Two factor H-related proteins from the mouse: expression analysis and functional characterization.	CFH CFHR4 CFHR3	5.39e-09	3	62	3	17028856
Pubmed	Localization of complement factor H gene expression and protein distribution in the mouse outer retina.	CFH CFHR4 CFHR3	5.39e-09	3	62	3	25684976
Pubmed	CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome.	CFH CFHR4 CFHR3	2.16e-08	4	62	3	36793547
Pubmed	Identification and sequence analysis of four complement factor H-related transcripts in mouse liver.	CFH CFHR4 CFHR3	5.38e-08	5	62	3	1689298
Pubmed	Molecular basis of C-reactive protein binding and modulation of complement activation by factor H-related protein 4.	CFH CFHR4 CFHR3	5.38e-08	5	62	3	20042240
Pubmed	A radiation hybrid map of complement factor H and factor H-related genes.	CFH CFHR4 CFHR3	5.38e-08	5	62	3	10380701
Pubmed	Sequence and Expression of Complement Factor H Gene Cluster Variants and Their Roles in Age-Related Macular Degeneration Risk.	CFH CFHR4 CFHR3	1.07e-07	6	62	3	27196323
Pubmed	Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.	CFH CFHR4 CFHR3	1.07e-07	6	62	3	17438673
Pubmed	Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.	CFH CFHR4 CFHR3	1.88e-07	7	62	3	19861685
Pubmed	Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome.	CFH CFHR4 CFHR3	4.50e-07	9	62	3	20059470
Pubmed	FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation.	CFH CFHR4 CFHR3	4.50e-07	9	62	3	28533443
Pubmed	Genetic Atypical Hemolytic-Uremic Syndrome	CFH CFHR4 CFHR3	8.81e-07	11	62	3	20301541
Pubmed	Complement Factor H Modulates Splenic B Cell Development and Limits Autoantibody Production.	CFH CFHR4	3.13e-06	2	62	2	31354740
Pubmed	Absence of complement factor H reduces physical performance in C57BL6 mice.	CFH CFHR4	3.13e-06	2	62	2	32962822
Pubmed	Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings.	CFH CFHR4	3.13e-06	2	62	2	20538999
Pubmed	Inheritance, hormonal regulation and properties of polymorphic murine antigens Mud1 and Mud2.	CFH CFHR4	3.13e-06	2	62	2	4992636
Pubmed	Retinal changes precede visual dysfunction in the complement factor H knockout mouse.	CFH CFHR4	3.13e-06	2	62	2	23844226
Pubmed	Prediction from sequence comparisons of residues of factor H involved in the interaction with complement component C3b.	CFH CFHR4	3.13e-06	2	62	2	8615824
Pubmed	Cadmium Induces Glomerular Endothelial Cell-Specific Expression of Complement Factor H via the -1635 AP-1 Binding Site.	CFH CFHR4	3.13e-06	2	62	2	30642982
Pubmed	Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.	CFH CFHR4	3.13e-06	2	62	2	26374608
Pubmed	A gene locus concerned with an antigenic serum substance in Mus musculus.	CFH CFHR4	3.13e-06	2	62	2	4955525
Pubmed	Analysis of complement factor H mRNA expression: dexamethasone and IFN-gamma increase the level of H in L cells.	CFH CFHR4	3.13e-06	2	62	2	2533512
Pubmed	Complement factor H: spatial and temporal expression and localization in the eye.	CFH CFHR4	3.13e-06	2	62	2	16936129
Pubmed	Watching synchronous mitochondrial respiration in the retina and its instability in a mouse model of macular degeneration.	CFH CFHR4	3.13e-06	2	62	2	33558624
Pubmed	Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration.	CFH CFHR4	3.13e-06	2	62	2	29398083
Pubmed	Complement factor H Y402H polymorphism results in diminishing CD4+ T cells and increasing C-reactive protein in plasma.	CFH CFHR4	3.13e-06	2	62	2	37940659
Pubmed	Comparative analysis of the properties and ligand binding characteristics of CspZ, a factor H binding protein, derived from Borrelia burgdorferi isolates of human origin.	CFH CFHR4	3.13e-06	2	62	2	19620346
Pubmed	Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma.	GAS1 OCLN	3.13e-06	2	62	2	28184927
Pubmed	Complement factor H regulates retinal development and its absence may establish a footprint for age related macular degeneration.	CFH CFHR4	3.13e-06	2	62	2	30705315
Pubmed	Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier.	OCLN CLDN2	3.13e-06	2	62	2	21415414
Pubmed	Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease.	CFH CFHR3	3.13e-06	2	62	2	20694013
Pubmed	A complement factor H homolog, heparan sulfation, and syndecan maintain inversin compartment boundaries in C. elegans cilia.	CFH CFHR4	3.13e-06	2	62	2	33859044
Pubmed	Regulation of age-related macular degeneration-like pathology by complement factor H.	CFH CFHR4	3.13e-06	2	62	2	25991857
Pubmed	Activation of TLR7-mediated autophagy increases epileptic susceptibility via reduced KIF5A-dependent GABAA receptor transport in a murine model.	TLR7 KIF5A	3.13e-06	2	62	2	37258573
Pubmed	Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients.	CFH CFHR4	3.13e-06	2	62	2	29288229
Pubmed	Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells.	CFH CFHR4	3.13e-06	2	62	2	33708358
Pubmed	Serological survey of complement factor H in common laboratory and wild mice: a new third allotype.	CFH CFHR4	3.13e-06	2	62	2	2522412
Pubmed	Absence of complement factor H alters bone architecture and dynamics.	CFH CFHR4	3.13e-06	2	62	2	30107932
Pubmed	Murine Factor H Co-Produced in Yeast With Protein Disulfide Isomerase Ameliorated C3 Dysregulation in Factor H-Deficient Mice.	CFH CFHR4	3.13e-06	2	62	2	34054871
Pubmed	Factor H binding to PspC of Streptococcus pneumoniae increases adherence to human cell lines in vitro and enhances invasion of mouse lungs in vivo.	CFH CFHR4	3.13e-06	2	62	2	17562771
Pubmed	Aged complement factor H knockout mice kept in a clean barriered environment have reduced retinal pathology.	CFH CFHR4	3.13e-06	2	62	2	27397653
Pubmed	Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration.	CFH CFHR4	3.13e-06	2	62	2	29392311
Pubmed	Phage display of a human antibody against Clostridium tetani toxin.	IGKV1-39 IGKV1D-39	3.13e-06	2	62	2	7926831
Pubmed	Complement Factor H-Related 3 Enhanced Inflammation and Complement Activation in Human RPE Cells.	CFH CFHR3	3.13e-06	2	62	2	34819935
Pubmed	The critical role of complement alternative pathway regulator factor H in allergen-induced airway hyperresponsiveness and inflammation.	CFH CFHR4	3.13e-06	2	62	2	22174452
Pubmed	Loss of Complement Factor H in Plasma Increases Endothelial Cell Migration.	CFH CFHR4	3.13e-06	2	62	2	28819420
Pubmed	Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids.	CFH CFHR4	3.13e-06	2	62	2	22875704
Pubmed	Local complement factor H protects kidney endothelial cell structure and function.	CFH CFHR4	3.13e-06	2	62	2	34139209
Pubmed	Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse model.	CFH CFHR4	3.13e-06	2	62	2	23799019
Pubmed	Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis.	CFH CFHR4	3.13e-06	2	62	2	32849636
Pubmed	Complement factor h is critical in the maintenance of retinal perfusion.	CFH CFHR4	3.13e-06	2	62	2	19541934
Pubmed	Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction.	CFH CFHR4	3.13e-06	2	62	2	17921253
Pubmed	The role of complement dysregulation in AMD mouse models.	CFH CFHR4	3.13e-06	2	62	2	24664701
Pubmed	Mitochondrial decline precedes phenotype development in the complement factor H mouse model of retinal degeneration but can be corrected by near infrared light.	CFH CFHR4	3.13e-06	2	62	2	26149919
Pubmed	Murine protein H is comprised of 20 repeating units, 61 amino acids in length.	CFH CFHR4	3.13e-06	2	62	2	2940596
Pubmed	A receptor for the complement regulator factor H increases transmission of trypanosomes to tsetse flies.	CFH CFHR4	3.13e-06	2	62	2	32165615
Pubmed	Death by color: differential cone loss in the aging mouse retina.	CFH CFHR4	3.13e-06	2	62	2	24929970
Pubmed	Cfh genotype interacts with dietary glycemic index to modulate age-related macular degeneration-like features in mice.	CFH CFHR4	3.13e-06	2	62	2	24370827
Pubmed	Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis.	CFH CFHR4	3.13e-06	2	62	2	23436934
Pubmed	Treatment with 670 nm light up regulates cytochrome C oxidase expression and reduces inflammation in an age-related macular degeneration model.	CFH CFHR4	3.13e-06	2	62	2	23469078
Pubmed	Topical cyclodextrin reduces amyloid beta and inflammation improving retinal function in ageing mice.	CFH CFHR4	3.13e-06	2	62	2	25921262
Pubmed	Complement factor h limits immune complex deposition and prevents inflammation and scarring in glomeruli of mice with chronic serum sickness.	CFH CFHR4	3.13e-06	2	62	2	15574507
Pubmed	Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules.	CFH CFHR4	3.13e-06	2	62	2	23133374
Pubmed	Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice.	CFH CFHR4	3.13e-06	2	62	2	30808757
Pubmed	Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury.	CFH CFHR4	3.13e-06	2	62	2	21544060
Pubmed	Role of ocular complement factor H in a murine model of choroidal neovascularization.	CFH CFHR4	3.13e-06	2	62	2	20813971
Pubmed	The specific α-neurexin interactor calsyntenin-3 promotes excitatory and inhibitory synapse development.	CLSTN3 NRXN1	3.13e-06	2	62	2	24094106
Pubmed	Location of the mouse complement factor H gene (cfh) by FISH analysis and replication R-banding.	CFH CFHR4	3.13e-06	2	62	2	1486806
Pubmed	A chimeric Cfh transgene leads to increased retinal oxidative stress, inflammation, and accumulation of activated subretinal microglia in mice.	CFH CFHR4	3.13e-06	2	62	2	26030099
Pubmed	Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.	CFH CFHR4	3.13e-06	2	62	2	17517971
Pubmed	Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice.	CFH CFHR4	3.13e-06	2	62	2	20445496
Pubmed	Possible role of complement factor H in podocytes in clearing glomerular subendothelial immune complex deposits.	CFH CFHR4	3.13e-06	2	62	2	31133737
Pubmed	High-density lipoproteins are a potential therapeutic target for age-related macular degeneration.	CFH CFHR4	3.13e-06	2	62	2	32737203
Pubmed	A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H-Related 3 Gene in Atypical Hemolytic Uremic Syndrome.	CFH CFHR3	3.13e-06	2	62	2	26490391
Pubmed	Distinct and separable roles of the complement system in factor H-deficient bone marrow chimeric mice with immune complex disease.	CFH CFHR4	3.13e-06	2	62	2	16597679
Pubmed	AAV Gene Augmentation of Truncated Complement Factor H Differentially Rescues Ocular Complement Dysregulation in a Mouse Model.	CFH CFHR4	3.13e-06	2	62	2	37471073
Pubmed	Complement Factor H Serum Levels Determine Resistance to Pneumococcal Invasive Disease.	CFH CFHR4	3.13e-06	2	62	2	26802141
Pubmed	Expression of human complement factor H prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged Cfh knockout mice.	CFH CFHR4	3.13e-06	2	62	2	25447048
Pubmed	Structure of the murine complement factor H gene.	CFH CFHR4	3.13e-06	2	62	2	2972715
Pubmed	Complement factor H deficiency combined with smoking promotes retinal degeneration in a novel mouse model.	CFH CFHR4	3.13e-06	2	62	2	34775843
Pubmed	Genome-wide association study identifies susceptibility loci for IgA nephropathy.	CFH CFHR4 CFHR3	5.12e-06	19	62	3	21399633
Pubmed	Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent.	CFH CFHR3	9.37e-06	3	62	2	20581873
Pubmed	Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.	CFH CFHR3	9.37e-06	3	62	2	26163426
Pubmed	Complement factor H: sequence analysis of 221 kb of human genomic DNA containing the entire fH, fHR-1 and fHR-3 genes.	CFH CFHR3	9.37e-06	3	62	2	10781834
Pubmed	Association assessment of copy number polymorphism and risk of age-related macular degeneration.	CFH CFHR3	9.37e-06	3	62	2	21856016
Pubmed	Human Genetic Disorders Resulting in Systemic Selenoprotein Deficiency.	SEPSECS SECISBP2	9.37e-06	3	62	2	34884733
Pubmed	Epithelial permeability alterations in an in vitro air-liquid interface model of allergic fungal rhinosinusitis.	OCLN CLDN2	9.37e-06	3	62	2	22927233
Pubmed	Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.	CFH CFHR4	9.37e-06	3	62	2	12091909
Pubmed	Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin.	CFHR4 CFHR3	9.37e-06	3	62	2	10622723
Pubmed	Borrelia burgdorferi binding of host complement regulator factor H is not required for efficient mammalian infection.	CFH CFHR4	9.37e-06	3	62	2	17420242
Pubmed	Immunoglobulin genes of the kappa light chain type from two human lymphoid cell lines are closely related.	IGKV1-39 IGKV1D-39	9.37e-06	3	62	2	6091049
Pubmed	Complement Regulatory Protein Factor H Is a Soluble Prion Receptor That Potentiates Peripheral Prion Pathogenesis.	CFH CFHR4	9.37e-06	3	62	2	29070671
Pubmed	Altered expression patterns of complement factor H and miR-146a genes in acute-chronic phases in experimental autoimmune encephalomyelitis mouse.	CFH CFHR4	9.37e-06	3	62	2	30972735
Pubmed	Retinal Basal Laminar Deposits in Complement fH/fP Mouse Model of Dense Deposit Disease.	CFH CFHR4	9.37e-06	3	62	2	30025090
Pubmed	Tight junction proteins in gallbladder epithelium: different expression in acute acalculous and calculous cholecystitis.	OCLN CLDN2	9.37e-06	3	62	2	17283368
Pubmed	Comparison of surface recognition and C3b binding properties of mouse and human complement factor H.	CFH CFHR4	9.37e-06	3	62	2	16023208
Pubmed	Location of theSas-1 locus on mouse chromosome 1.	CFH CFHR4	9.37e-06	3	62	2	21302086
Pubmed	Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency.	CFH CFHR4	9.37e-06	3	62	2	23184055
Pubmed	A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts.	OCLN CLDN2	9.37e-06	3	62	2	9786950
Pubmed	Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy.	CFH CFHR3	9.37e-06	3	62	2	25205734
Cytoband	1q32	CFH CFHR4 CFHR3	4.13e-05	49	62	3	1q32
Cytoband	Ensembl 112 genes in cytogenetic band chr1q31	CFH CFHR4 CFHR3	1.48e-04	75	62	3	chr1q31
GeneFamily	Complement system\|Sushi domain containing	CFH CFHR4 CFHR3	5.83e-05	36	38	3	492
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CFH CFHR4 CFHR3	2.32e-04	57	38	3	1179
GeneFamily	Fibronectin type III domain containing	L1CAM ROS1 USH2A	4.57e-03	160	38	3	555
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG1 PLEKHG3	8.48e-03	66	38	2	722
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG1 APPL2 PLEKHG3	9.17e-03	206	38	3	682
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5	CLSTN3 ZFHX4 NRK SLC26A5 P4HA3 RBM47 EPAS1	1.11e-05	276	59	7	Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4	CLSTN3 ZFHX4 NRK MAPKAPK3 TENT5C P4HA3 EPAS1	1.83e-05	298	59	7	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4
CoexpressionAtlas	dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_1000	NRXN1 NRK L1CAM P4HA3 PGAP4 KIF5A	2.60e-05	211	59	6	gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5	CLSTN3 ZFHX4 NRK P4HA3 RBM47 EPAS1	5.86e-05	244	59	6	Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3	CLSTN3 ZFHX4 NRK TENT5C P4HA3 EPAS1	6.56e-05	249	59	6	Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000	CLSTN3 ZFHX4 NRXN1 ACRBP PLEKHG3 NRK GAS1 TENT5C P4HA3 RBM47 EPAS1	6.56e-05	973	59	11	Facebase_RNAseq_e9.5_Olfactory Placode_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1	CLSTN3 ZFHX4 NRK MAPKAPK3 P4HA3 RBM47 EPAS1	7.34e-05	371	59	7	Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3	CLSTN3 ZFHX4 NRK MAPKAPK3 SLC26A5 P4HA3 EPAS1	9.10e-05	384	59	7	Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000	CLSTN3 GPR50 ZFHX4 NRXN1 TAS1R3 NRK MAPKAPK3 TENT5C P4HA3 EPAS1	3.02e-04	967	59	10	Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000	CLSTN3 GPR50 ZFHX4 NRXN1 NRK MAPKAPK3 TENT5C P4HA3 RBM47 EPAS1	3.02e-04	967	59	10	Facebase_RNAseq_e9.5_Maxillary Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000	CLSTN3 GPR50 ZFHX4 NRXN1 NRK MAPKAPK3 SLC26A5 TENT5C P4HA3 EPAS1	3.04e-04	968	59	10	Facebase_RNAseq_e9.5_Facial Mesenchyne_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000	CLSTN3 GPR50 ZFHX4 NRXN1 NRK MAPKAPK3 TENT5C P4HA3 RBM47 EPAS1	3.14e-04	972	59	10	Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000	CLSTN3 GPR50 ZFHX4 NRXN1 PLEKHG3 NRK MAPKAPK3 TENT5C P4HA3 EPAS1	3.25e-04	976	59	10	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFHX4 NRXN1 NRK ROS1 KIF5A USH2A	2.19e-07	184	62	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFHX4 NRXN1 NRK ROS1 KIF5A USH2A	2.19e-07	184	62	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFHX4 NRXN1 NRK ROS1 KIF5A USH2A	2.19e-07	184	62	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 NRXN1 MS4A1 TAS1R3 IGKV1D-39	2.07e-06	149	62	5	2cd860b96ed4be4d26844085d464961c1418054a
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 PLEKHG1 MS4A1 TAS1R3 IGKV1D-39	3.84e-06	169	62	5	307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-39 TENT5C IGKV1D-39 CPVL MFSD1	4.30e-06	173	62	5	b335ca2a247156eba821943b2b9fc9922230b409
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-39 PLEKHG1 MS4A1 TAS1R3 IGKV1D-39	5.36e-06	181	62	5	700adfb41e4e377530f0dd31be89e12f109f3469
ToppCell	Mild_COVID-19-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGKV1-39 PLEKHG1 MS4A1 TAS1R3 IGKV1D-39	5.65e-06	183	62	5	dea119e2988e954475f557f0bbe12556a83e81a4
ToppCell	B_cell_maturation-plasma\|World / Lineage and Cell class	IGKV1-39 PSAT1 TAS1R3 TENT5C IGKV1D-39	5.65e-06	183	62	5	0c3cb61912df05f1beba1004540770ef1a4de786
ToppCell	wk_15-18-Hematologic_Lymphocytic-B-CD5+_CCL22-_mature_B\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	IGKV1-39 PLEKHG1 MS4A1 TENT5C IGKV1D-39	5.80e-06	184	62	5	18aa9c43b79d12c9e420dfd9822745c022be6789
ToppCell	Severe_COVID-19-B_cell\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGKV1-39 PSAT1 MS4A1 TENT5C IGKV1D-39	6.61e-06	189	62	5	59ce8f15f413557d2059ee6b53ba5957b864cb8e
ToppCell	BAL-Severe-Lymphocyte-B\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-39 PSAT1 MS4A1 TENT5C IGKV1D-39	6.78e-06	190	62	5	d55b9f9b82bd2b2e1ea2446813fce04f04a1dcdf
ToppCell	cellseq2-Immune-Lymphocytic_B-Lymphocytic_B\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGKV1-39 MS4A1 TAS1R3 TENT5C IGKV1D-39	6.96e-06	191	62	5	17746a32f723c078aba1f7e320b0e3f1ab8bf5c6
ToppCell	cellseq2-Immune-Lymphocytic_B\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGKV1-39 MS4A1 TAS1R3 TENT5C IGKV1D-39	6.96e-06	191	62	5	c2c450df810f83163987cd0f7ed9b50025cd3de1
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PSAT1 NRXN1 L1CAM PGAP4 KIF5A	7.32e-06	193	62	5	d5930f7bd9b299f792212d40a3272a37adf64a82
ToppCell	Tracheal-10x5prime-Stromal-Schwann\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NRXN1 L1CAM TTYH2 KIF5A TMEM215	7.89e-06	196	62	5	b6226163d9fc93ecfff2115bb74408303a000490
ToppCell	Parenchymal-10x5prime-Stromal-Mesofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFH ZFHX4 NRK GAS1 WNK4	8.08e-06	197	62	5	88a86286b9c3ea3b076d7464faec42d0392ee7f8
ToppCell	Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFH ZFHX4 NRK GAS1 WNK4	8.08e-06	197	62	5	2773d2eb5f232a7e49da116efffcb6bf5eb90810
ToppCell	Sigmoid-(5)_Dendritic_cell-(51)_cDC1\|Sigmoid / shred on region, Cell_type, and subtype	STAC3 TTYH2 CPVL TGM5 MGAM2	8.70e-06	200	62	5	4ce0a2238c90622e41fd86ac4b7d82adf4af2c3b
ToppCell	Sigmoid-Dendritic_cell-cDC1\|Sigmoid / Region, Cell class and subclass	STAC3 TTYH2 CPVL TGM5 MGAM2	8.70e-06	200	62	5	3523ec986e8c9e176e08836c974b1de8b56d8b16
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANKAR STAC3 TLR7 CPVL	2.23e-05	118	62	4	7e6cb77fa9154f2da985c455bb6a24d6029cc8d6
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZFHX4 SLC26A5 P4HA3 CFAP43	3.07e-05	128	62	4	2cf0384240a4a663869cf6b27d954236f6214a9a
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SEPSECS ACRBP ELOVL1 USH2A	3.36e-05	131	62	4	1823cab28fab40486247ca92104267b1e370bdc1
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKAR SLC26A5 ROS1 USH2A	4.99e-05	145	62	4	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	LPS-IL1RA-Myeloid-Dendritic_cells-Monocytes-Macrophages\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACRBP STAC3 TLR7 CPVL	5.55e-05	149	62	4	a464c0fd54e3c9e1d40d95b49489cb9371dd7c24
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CLSTN3 MS4A1 ACRBP WNK4	7.14e-05	159	62	4	1dde4d19cc0fde7ebbccb4c31bb845a92206021b
ToppCell	368C-Lymphocytic-Plasma_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	7.68e-05	162	62	4	c21a54310b239d999bbc9d8fb5e8fda16e0bc336
ToppCell	368C-Lymphocytic-Plasma_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	7.68e-05	162	62	4	f945688815229c8386cbcbf46deee7df316fa8d3
ToppCell	facs-Trachea-18m-Hematologic-lymphocytic-B_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MS4A1 TENT5C SECISBP2 RBM47	8.05e-05	164	62	4	4274a4f225cabf61f0fe27d8ea162b4eba612f87
ToppCell	facs-Trachea-18m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MS4A1 TENT5C SECISBP2 RBM47	8.05e-05	164	62	4	d62143450f59097ad4b34603a6257f897a769ead
ToppCell	367C-Myeloid-Monocyte-CD16+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 MS4A1 MAPKAPK3 P4HA3	8.05e-05	164	62	4	1aff83fc73b4e41e6f0d4b04dbca153bcc7a3518
ToppCell	facs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSAT1 ACRBP PLEKHG3 L1CAM	8.44e-05	166	62	4	a2ce44702a0cd5fa5872cac3302d3c451205feef
ToppCell	facs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSAT1 ACRBP PLEKHG3 L1CAM	8.44e-05	166	62	4	0f641302a6b71c4badaaf20f51162bfc2386b167
ToppCell	ICU-NoSEP-Lymphocyte-T_NK-MAIT\|ICU-NoSEP / Disease, Lineage and Cell Type	PSAT1 CDC42BPA ANKAR OCLN	8.44e-05	166	62	4	d3fa2e42497201f1ca57f4f977fbaa0def950033
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_E\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	HOXA6 GAS1 P4HA3 RBM47	8.64e-05	167	62	4	b5d15773be32cd277125fd3b4056a8fefaefa5ec
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 PLEKHG1 MS4A1 IGKV1D-39	9.25e-05	170	62	4	ee2ee67d90ae4596de8ccd620e37c82cf51651d4
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 PLEKHG1 MS4A1 IGKV1D-39	9.25e-05	170	62	4	d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a
ToppCell	Control-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	9.25e-05	170	62	4	fb05f49b7113470995b3c16683c54dc1a660b73a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 PLEKHG1 MS4A1 IGKV1D-39	9.25e-05	170	62	4	52787f6d529c285d9f0c04cc022710ead5b89b3f
ToppCell	367C-Myeloid-Monocyte-CD16+_Monocyte\|Monocyte / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 MS4A1 MAPKAPK3 P4HA3	9.68e-05	172	62	4	fb8ab2576b5c38db63573a3bf46b8d9d634c4999
ToppCell	Plasma_cells\|World / lung cells shred on cell class, cell subclass, sample id	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	9.90e-05	173	62	4	52a387e2a4694af61a9223a4c2ecf4e6f762c064
ToppCell	AT1_cells-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	PSAT1 NRK SLC26A5 PGAP4	9.90e-05	173	62	4	b29816427428c7053017477f59b828bf1357f3b2
ToppCell	wk_15-18-Hematologic_Lymphocytic-B-CD5+_CCL22+_mature_B\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	IGKV1-39 MS4A1 IGKV1D-39 HSF5	1.03e-04	175	62	4	fa53ea81ad943a2cd266114829135cbcbcf2f634
ToppCell	wk_08-11-Mesenchymal-Chondrocyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CFH PLEKHG1 NRK WNK4	1.06e-04	176	62	4	1af28b701c4598ce761f85adbd5d79e4918d265a
ToppCell	wk_15-18-Epithelial-PNS-Schwann_precursor\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PSAT1 NRXN1 L1CAM PGAP4	1.08e-04	177	62	4	5357359e6c2161a37f39a6b3b78449f5cbc327d1
ToppCell	(2)_Plasma_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	1.08e-04	177	62	4	ed3c936bb69f9bc7291b4f6cde1d204078117c48
ToppCell	-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	IGKV1-39 MS4A1 TENT5C IGKV1D-39	1.08e-04	177	62	4	ae2d2e138946535596fa30a55207f261cafda461
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-8\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MS4A1 ANKAR TLR7 KIF5A	1.08e-04	177	62	4	066e7500e7bdde88a7914f50a4661d8adf6db925
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 MS4A1 TENT5C IGKV1D-39	1.10e-04	178	62	4	107dae8b00c4257697a63700e72bb434cdb8406f
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAS1 CFAP43 OCLN DMRT1	1.10e-04	178	62	4	6d9ecfaeb50d562899380de379ebf7b99fd8adc9
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAS1 CFAP43 OCLN DMRT1	1.10e-04	178	62	4	d3f518cd75b02e85d45cbb9b2eff30f0272512a8
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGKV1-39 MS4A1 TENT5C IGKV1D-39	1.15e-04	180	62	4	cd04d7bf92986a5b8a0193c9b92ec47da3929bac
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	1.15e-04	180	62	4	e3877f6ef5f54ff689058b4c996ab1851822f871
ToppCell	cellseq-Immune-Lymphocytic_B\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGKV1-39 MS4A1 TENT5C IGKV1D-39	1.15e-04	180	62	4	663a800ab70e7ab7d13183417f9c1ed36907aa5e
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-2\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MS4A1 ANKAR TLR7 KIF5A	1.18e-04	181	62	4	75035a3211e524bb659b82e6979f7d3a3121ae70
ToppCell	droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRXN1 L1CAM TTYH2 P4HA3	1.20e-04	182	62	4	6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFH PLEKHG1 TENT5C OCLN	1.20e-04	182	62	4	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	10x5'-Lung-Lymphocytic_B\|Lung / Manually curated celltypes from each tissue	IGKV1-39 PLEKHG1 MS4A1 IGKV1D-39	1.20e-04	182	62	4	310f94437d197eaaaf6e30e68063b33e94befe77
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLEKHG1 MS4A1 TAS1R3 IGKV1D-39	1.23e-04	183	62	4	82fe14fc7039415de41bdfd615a1380bed99f560
ToppCell	droplet-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH NRK GAS1 TMEM215	1.23e-04	183	62	4	a253ad65673fce6cb453e709cb235ce7cbfa18b7
ToppCell	Mild-Lymphoid-B\|Mild / Condition, Lineage, Cell class and cell subclass	IGKV1-39 PLEKHG1 MS4A1 IGKV1D-39	1.23e-04	183	62	4	9b64d2d143525e6f48a191facfd101462ff36324
ToppCell	droplet-Lung-nan-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH NRK GAS1 TMEM215	1.23e-04	183	62	4	ddc45fb591ba0ce3fa05c08051d58286a89ef835
ToppCell	Mild-Lymphoid-B-\|Mild / Condition, Lineage, Cell class and cell subclass	IGKV1-39 PLEKHG1 MS4A1 IGKV1D-39	1.23e-04	183	62	4	b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	1.23e-04	183	62	4	cf5c98f451a568308c52da5c926543dd4836c6b2
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ZFHX4 NRK TLR7 TMEM215	1.25e-04	184	62	4	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGKV1-39 PLEKHG1 MS4A1 IGKV1D-39	1.25e-04	184	62	4	3f8a359e40bebe58545f708682e5e5d1b70cf5cb
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGKV1-39 PLEKHG1 MS4A1 IGKV1D-39	1.25e-04	184	62	4	64bede8db709fd32f40c03265b96f0b12155bb8a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-39 PLEKHG1 MS4A1 IGKV1D-39	1.28e-04	185	62	4	609080adb2cfb105bb7b8efb617553833299f371
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	1.28e-04	185	62	4	6ec009e48e50471c28e914c402f500e56a88f8f2
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLEKHG1 GAS1 OCLN WNK4	1.28e-04	185	62	4	af86e75096c1812ae27a78405355957ee8043d84
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	1.28e-04	185	62	4	0fff2608f507e019ebb69c27e58fd5be3b049bef
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	1.28e-04	185	62	4	79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	1.28e-04	185	62	4	f49ad6401b2abd089e30eba245b11b5031ea2318
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	1.28e-04	185	62	4	08bc817908076734d66f2805cb954141f2cc5a18
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	1.28e-04	185	62	4	1704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell	10x5'-Liver-Lymphocytic_B_plasma\|Liver / Manually curated celltypes from each tissue	IGKV1-39 PSAT1 TAS1R3 IGKV1D-39	1.31e-04	186	62	4	a2c7430781f432c9c90ac4d620f4518ff767a223
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFH ZFHX4 NRK GAS1	1.31e-04	186	62	4	7812ed80d2378aca9957ef22fc3c8fb7fb58434b
ToppCell	Mild_COVID-19-B_cell-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGKV1-39 PLEKHG1 MS4A1 IGKV1D-39	1.31e-04	186	62	4	855a5a00ba2aa1b5c63b8db56d026ddecc546050
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	CFH PLEKHG1 TENT5C OCLN	1.34e-04	187	62	4	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 MS4A1 TENT5C IGKV1D-39	1.34e-04	187	62	4	8089ae6ee59533a090fe0b19bdd057fba8fa11de
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ZFHX4 NRXN1 GAS1	1.36e-04	188	62	4	c32d023a69b6da79687ff8fa7485e7499db57046
ToppCell	severe_COVID-19-Plasmablast\|World / disease group, cell group and cell class (v2)	IGKV1-39 PSAT1 TAS1R3 IGKV1D-39	1.36e-04	188	62	4	25ca19af4ac419a0f5026a6ccbd8b554b268a6f3
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ZFHX4 NRXN1 GAS1	1.36e-04	188	62	4	1cd5a4d744bd3777246958ea5eb94388a5cbad81
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRXN1 MS4A1 TTYH2 TMEM215	1.36e-04	188	62	4	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	cellseq2-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	1.36e-04	188	62	4	33360f1c30315d9772731c9067834dc059172b79
ToppCell	BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGKV1-39 PSAT1 TENT5C IGKV1D-39	1.39e-04	189	62	4	b0fcbe13a91a4b8dfa507b7a484f45477ef31609
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH NRK OCLN WNK4	1.39e-04	189	62	4	8e583ec4df0f5b79ce5211cc99ecd8616d180bde
ToppCell	BAL-Severe-Lymphocyte-B-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-39 PSAT1 TENT5C IGKV1D-39	1.39e-04	189	62	4	d5d25f4151ea96e2d4b3a0e0910e7ff995eaf752
ToppCell	Control-B_intermediate-6\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MS4A1 TAS1R3 STAC3 ADAM32	1.39e-04	189	62	4	11cb9a16f1de8f60af2073ed7ea6d4f41c02f299
ToppCell	Severe_COVID-19-B_cell-Plasmablast\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGKV1-39 PSAT1 TENT5C IGKV1D-39	1.39e-04	189	62	4	d7bfefc8c35374c5288807349a76dbb10e84c52b
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGKV1-39 TAS1R3 TENT5C IGKV1D-39	1.39e-04	189	62	4	5a42be62552d912d0abf68f00d75ac80bbd69f2c
ToppCell	BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-39 PSAT1 TENT5C IGKV1D-39	1.39e-04	189	62	4	0f0607642eecc66222d23afe6d77b6872343cb8e
ToppCell	wk_15-18-Hematologic_Lymphocytic-B-Immature_B\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	IGKV1-39 PLEKHG1 MS4A1 IGKV1D-39	1.39e-04	189	62	4	5776f842b3047d21ccdc44db884bfd210823c7da
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH NRK OCLN WNK4	1.39e-04	189	62	4	fb2253b8463d08b3d28e952a31a23dea2c2d986b
ToppCell	wk_15-18-Hematologic_Lymphocytic-B-CD5-_Mature_B\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	IGKV1-39 PLEKHG1 MS4A1 IGKV1D-39	1.42e-04	190	62	4	ade43d1d1f8909b8526a23152acf3c26f160f836
ToppCell	BAL-Severe-Lymphocyte-B\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 PSAT1 TENT5C IGKV1D-39	1.42e-04	190	62	4	e82fefea5ac03470d10463832d3efd2380895860
ToppCell	BAL-Severe-Lymphocyte-B-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 PSAT1 TENT5C IGKV1D-39	1.42e-04	190	62	4	9560722facaf3516936fcbc2a900a405fd85e5d0
ToppCell	BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 PSAT1 TENT5C IGKV1D-39	1.42e-04	190	62	4	7fbaf46bf24d46543047582f0d262f3523e28eb4
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFH PLEKHG1 TENT5C OCLN	1.45e-04	191	62	4	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRXN1 MS4A1 TTYH2 TMEM215	1.45e-04	191	62	4	3387b95a3f2445c672d407922fdce3a91eabaef8
Drug	(2S)-N-[4-(aminomethyl)-1,1-dioxothian-4-yl]-2-[1-(benzenesulfonamido)ethylideneamino]-3-(1-methylcyclopentyl)propanamide	CFH CFHR3	6.38e-06	2	58	2	CID011840931
Disease	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement	CFH CFHR4 CFHR3	2.73e-08	4	57	3	EFO_0803292
Disease	Atypical hemolytic-uremic syndrome	CFH CFHR4 CFHR3	5.69e-07	9	57	3	cv:C2931788
Disease	Hemolytic-uremic syndrome	CFH CFHR4 CFHR3	5.69e-07	9	57	3	cv:C0019061
Disease	c3d:C3 ratio	CFH CFHR4	3.67e-06	2	57	2	EFO_0008543
Disease	endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase measurement	CFH CFHR3	1.10e-05	3	57	2	EFO_0801568
Disease	anaphase-promoting complex subunit 7 measurement	CFH CFHR3	1.10e-05	3	57	2	EFO_0801381
Disease	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	CFH CFHR3	1.10e-05	3	57	2	C2749604
Disease	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	CFH CFHR3	1.10e-05	3	57	2	235400
Disease	calnexin measurement	CFH CFHR4	1.10e-05	3	57	2	EFO_0801444
Disease	complement factor H-related protein 4A measurement	CFH CFHR4	1.10e-05	3	57	2	EFO_0600057
Disease	Hemolytic uremic syndrome, atypical, susceptibility to, 1	CFH CFHR3	1.10e-05	3	57	2	cv:C2749604
Disease	histone-lysine N-methyltransferase 2D measurement	CFH CFHR4	1.10e-05	3	57	2	EFO_0801683
Disease	Meningococcal Infections	CFH CFHR3	2.19e-05	4	57	2	C0025303
Disease	kallikrein-5 measurement	CFH CFHR4	2.19e-05	4	57	2	EFO_0020515
Disease	Autism Spectrum Disorders	GPR50 NRXN1 ANKRD11 USH2A	2.25e-05	85	57	4	C1510586
Disease	Age related macular degeneration	CFH CFHR4 CFHR3	2.67e-05	30	57	3	C0242383
Disease	Complement deficiency disease	CFH CFHR4 CFHR3	3.58e-05	33	57	3	C0272242
Disease	complement C1s subcomponent measurement	CFH CFHR4	5.47e-05	6	57	2	EFO_0008091
Disease	complement factor H measurement	CFH RBM47 CFHR4	6.92e-05	41	57	3	EFO_0008097
Disease	atypical hemolytic-uremic syndrome (is_implicated_in)	CFH CFHR3	1.02e-04	8	57	2	DOID:0080301 (is_implicated_in)
Disease	leukocyte immunoglobulin-like receptor subfamily A member 5 measurement	CFH CFHR4	1.31e-04	9	57	2	EFO_0801766
Disease	Atypical Hemolytic Uremic Syndrome	CFH CFHR3	1.63e-04	10	57	2	C2931788
Disease	hemopexin measurement	CFH CFHR4	1.99e-04	11	57	2	EFO_0008149
Disease	complement factor H-related protein 3 measurement	CFH USH2A CFHR4 CFHR3	3.24e-04	169	57	4	EFO_0600056
Disease	Spastic Paraplegia, Hereditary	L1CAM KIF5A	3.29e-04	14	57	2	C0037773
Disease	Age-related macular degeneration	CFH CFHR3	5.50e-04	18	57	2	cv:C0242383
Disease	coagulation factor measurement	CFH CFHR4	6.81e-04	20	57	2	EFO_0004634
Disease	COVID-19 (is_implicated_in)	CFH TLR7	7.52e-04	21	57	2	DOID:0080600 (is_implicated_in)
Disease	temperament and character inventory	SEPSECS NRXN1	9.85e-04	24	57	2	EFO_0004825
Disease	azoospermia (implicated_via_orthology)	CDC42BPA YIPF7	1.25e-03	27	57	2	DOID:14227 (implicated_via_orthology)
Disease	complement factor H-related protein 2 measurement	CFH CFHR4	1.44e-03	29	57	2	EFO_0600055

Protein segments in the cluster

Peptide	Gene	Start	Entry
PQCYATQYQDYSLSS	EPAS1	801	Q99814
QIYGFCSQVPYICSY	CFAP43	601	Q8NDM7
DYCITPYAYNQDQHS	ERVK13-1	381	Q9NX77
QAPQCYAEYVTYTGS	ANKRD11	2461	Q6UB99
QYSQICYYEILTPNT	CLSTN3	176	Q9BQT9
LSLPCQIGSQVYYYN	C2orf78	201	A6NCI8
YIQYPNYCSFKSQQC	ACRBP	481	Q8NEB7
TYSSDIQTQCYYQGN	ADAM32	86	Q8TC27
SVYAPASSVEYQCQN	CFH	1126	P08603
NSPSTQYCYSIQSLF	MS4A1	176	P11836
SSSYSNEQQLCPYAA	MKRN2	161	Q9H000
QQPSYVYSCDPYTLA	RBM47	341	A0AV96
NQYQACYPSSSFGVT	EYA3	206	Q99504
QIYALCNQFYTPAAT	OCLN	211	Q16625
YCSYETNSNAYLLLQ	P4HA3	321	Q7Z4N8
CQICYLNYPNSYFTG	ARIH1	186	Q9Y4X5
YDQSSSCQLPPAYYD	ANKAR	126	Q7Z5J8
AYDSYVAICNPLQYS	OR52E2	121	Q8NGJ4
QPEDFATYYCQQSYS	IGKV1D-39	101	P04432
TYTSPCFYQQSNSVL	HOXA6	51	P31267
QNALQTPCYTPYYVA	MAPKAPK3	196	Q16644
CYYDTIPNYVASDIQ	MGAM2	946	Q2M2H8
YDPRTYTCIFNYLNN	GPR50	171	Q13585
DPSYFQNVTGCSNYY	CPVL	301	Q9H3G5
ASLSPQYVSYNQSSY	L1CAM	1061	P32004
SYFCYDNPAALQTQV	MFSD1	56	Q9H3U5
CSYAYNQYAEACAPV	GAS1	61	P54826
YVYCLESSLQTYNPD	PGAP4	191	Q9BRR3
YFCYDLSQNPIQSSS	NRXN1	291	Q9ULB1
YTSQYSNSLNPFYTL	GUCA1ANB	81	X6R8D5
PYYELQGSNYVTCSN	CFHR3	241	Q02985
LSSLQYYCALNALQY	APPL2	176	Q8NEU8
ISQYYFMSSCNYQYP	ELOVL1	216	Q9BW60
GQSYSYYCDQNFVTP	CFHR4	296	Q92496
VYVPQSRVEYQCQSY	CFHR4	476	Q92496
QCQSYYELQGSNYVT	CFHR4	486	Q92496
RSNYYDAYQAQPLAT	CLDN2	191	P57739
PECISYTNSLFQNYQ	KIF5A	941	Q12840
QPEDFATYYCQQSYS	IGKV1-39	101	P01597
NSCQPQSYLVRNYHY	KRTAP24-1	196	Q3LI83
RTCYPLSYFSYGNQT	KRTAP25-1	41	Q3LHN0
QCGDYYSALYTVPTQ	SEC24B	86	O95487
YYNNLYNCPQYSMAL	DMRT1	221	Q9Y5R6
NNNYYEAPSCPRASY	NRK	981	Q7Z2Y5
KYSNYTPSAQYSQAY	HSF5	291	Q4G112
YSQAYYPTAVLQCCS	HSF5	301	Q4G112
LQPYSQYNFSLVACT	USH2A	4411	O75445
TQYCNNYPNSVAALT	PLEKHG3	181	A1L390
NAPIYYANSDLYSNA	SLC26A5	541	P58743
NLNPDASYVYYCANE	PSAT1	141	Q9Y617
YLYNQPSCYRGFQTV	SECISBP2	111	Q96T21
NPSSCCYNAPYLSVY	CDC42BPA	1451	Q5VT25
CYNAPYLSVYSENAV	CDC42BPA	1456	Q5VT25
TNVTCYYQPAPYVSD	TENT5C	351	Q5VWP2
TSCYYNSTLTNQKLY	RNASE13	121	Q5GAN3
FYQCPYCNYNSRDQS	ZFHX4	1171	Q86UP3
AAYCNYTQYQPRVLA	TAS1R3	126	Q7RTX0
QNSPYDRYCCYINQI	TMEM215	211	Q68D42
YYLYCSQSGSSPFQQ	TTYH2	296	Q9BSA4
AYVCNITNLQPYTSY	ROS1	1711	P08922
PCKISYSQYSQYLST	TGM5	576	O43548
QNCYYRNPCYVSYSI	TLR7	181	Q9NYK1
TCYVQGASPCQSYYV	XP32	131	Q5T750
TNNYPCAYLNAASAI	SEPSECS	426	Q9HD40
YTQYCTNYPRSVAVL	PLEKHG1	201	Q9ULL1
FQPASNSDYYSQSPY	YIPF7	91	Q8N8F6
AYSSPLYSNQQYACV	STAC3	151	Q96MF2
SEYPYSECQNAAQIY	WNK4	371	Q96J92